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Abstract
Background: In many countries, depressed individuals often first visit primary care settings for consultation, but a considerable
number of clinically depressed patients remain unidentified. Introducing additional screening tools may facilitate the diagnostic
process.
Objective: This study aimed to examine whether experience sampling method (ESM)-based measures of depressive affect and
behaviors can discriminate depressed from nondepressed individuals. In addition, the added value of actigraphy-based measures
was examined.
Methods: We used data from 2 samples to develop and validate prediction models. The development data set included 14 days
of ESM and continuous actigraphy of currently depressed (n=43) and nondepressed individuals (n=82). The validation data set
included 30 days of ESM and continuous actigraphy of currently depressed (n=27) and nondepressed individuals (n=27). Backward
stepwise logistic regression analysis was applied to build the prediction models. Performance of the models was assessed with
goodness-of-fit indices, calibration curves, and discriminative ability (area under the receiver operating characteristic curve
[AUC]).
Results: In the development data set, the discriminative ability was good for the actigraphy model (AUC=0.790) and excellent
for both the ESM (AUC=0.991) and the combined-domains model (AUC=0.993). In the validation data set, the discriminative
ability was reasonable for the actigraphy model (AUC=0.648) and excellent for both the ESM (AUC=0.891) and the
combined-domains model (AUC=0.892).
Conclusions: ESM is a good diagnostic predictor and is easy to calculate, and it therefore holds promise for implementation in
clinical practice. Actigraphy shows no added value to ESM as a diagnostic predictor but might still be useful when ESM use is
restricted.
(J Med Internet Res 2020;22(12):e22634) doi: 10.2196/22634
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Introduction
Depressive disorders represent a major public health concern
as they are the most prevalent psychiatric disorders and a leading
cause of disability worldwide [1,2]. In many countries, depressed
individuals often first visit primary care settings when they seek
help [3]. Even though most nondepressed individuals can be
accurately excluded in primary care [4], a considerable number
of clinically depressed patients remains unidentified [5]. Thus,
general practitioners can correctly identify between 41.7% and
53.0% of cases of depression with a sensitivity between 41.3%
and 59.0% and a specificity between 74.5% and 87.3% [4]. An
additional challenge in the detection of depression arises because
patients often present with undefined or somatic illness [6],
resulting in depression going undetected and often untreated
for a longer time period [7].
According to a meta-analysis on the clinical diagnosis of
depression in primary care, the accuracy of identification of
depression can be improved by prospective examination over
an extended period [4]. Therefore, introducing additional
screening tools that allow continuous monitoring during daily
life may facilitate the diagnostic process and improve referral
of depressed individuals to the right care providers. A good
candidate for a screening tool that holds particular value for
studying mood disorders is the experience sampling method
(ESM) [8]. Most commonly delivered via a smartphone, ESM
involves repeated, intensive sampling of respondents' current
affect, experiences, and behaviors while they are engaged in
their daily activities, in their natural environments [9].
Hypothetically, this might be an optimal way of detecting
depression risk, as a person can repeatedly assess his/her affect
and behaviors in daily life with minimal retrospective recall
bias [8]. Previous studies have shown that higher levels of
negative affect, which is commonly assessed with ESM, are
strongly associated with depression [10]. Furthermore, this
method comes closest to the advised method to do longitudinal
assessments of depressive symptoms [11,12]. A problem with
ESM, however, may be that it places too high a burden on the
patient, leading to reduced compliance [9]. Hence, ESM as a
screening tool may not be suitable for everyone, warranting the
exploration of more passive ways of collecting data as well.
A potential candidate for depression screening that involves
passive data collection is ambulatory assessment of actigraphy
data from sensors, such as activity trackers. Such activity
trackers are now widely used, and they provide ecologically
valid data about behavior [13-16]. The data derived from activity
trackers include patterns of sleep, physical activity, and circadian
rest-activity rhythm (RAR). Alterations in these patterns have
been found in depression [17-22] and contributed to objective
differentiation of depression subtypes [23]. Further, these
behavioral parameters are easily and passively measurable by
actigraphy and do not require any invasive procedure or active
participation from individuals. Therefore, they do not create an
additional burden for an individual [15]. However, it is important
to note that the alterations in these actigraphy patterns are not
specific for depression, since altered sleep, physical activity,
and RAR are present in many other health conditions [24,25].
Therefore, most likely, actigraphy may only be used in addition
to other measures when screening for depression. However, the
predictive value of actigraphy-based measures, alone and in
combination with other measures, for depression remains to be
examined.
Sleep, physical activity, and RAR domains are associated with
each other [26,27]. However, previous researchers who found
associations between actigraphy data and depression included
measures from only 1 or 2 of these domains (ie, studying
physical activity only, sleep only, or circadian RAR and sleep)
[20,21,28-30], with a rare exception [31]. Therefore, probably
not all actigraphy-based measures that have been previously
associated with depression will have a unique predictive value
as part of a multidimensional screening tool. Thus, it is currently
still unclear which combination of actigraphy measures are most
strongly associated with depression risk.
Using both ESM and actigraphy approaches together for
continuous and everyday monitoring of behavioral and affective
aspects in depression could be a promising screening tool. While
it is assumed that self-reports of depression-related affect and
behaviors as assessed with ESM predict depression better than
behavioral sensor data, this assumption has never been tested
before. To our knowledge, there is only 1 recent study that
attempted to predict depression by using both ESM and
actigraphy data; however, it was focused on the elderly, had a
smaller sample size (N=47), and had no external validation [32].
Currently, it is not yet clear how these approaches perform and
if they can be used for screening purposes, both separately and
in combination.
In this study, we examined (1) whether ESM-assessed
depression-related affect and behavior could discriminate
between depressed and nondepressed individuals, (2) whether
actigraphy data could discriminate between depressed and
nondepressed individuals, and (3) whether actigraphy has added
value with respect to the use of ESM. Therefore, we compared
the performance of the prediction models with ESM only and
actigraphy only to assess the added benefit of the individual
domains and then evaluated the performance of the prediction
model with both domains included. First, we hypothesized that
ESM measures would have a better discriminating ability in
distinguishing individuals with and without a diagnosis of
depression than actigraphy measures. Second, adding actigraphy
measures to the ESM prediction model would improve the
discriminating ability. To test these hypotheses, we used 2 data
sets for development and validation of the prediction models.
Methods
Study Population
We used data from the Netherlands Study of Depression and
Anxiety (NESDA) [33] to develop prediction models, and data
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from the Mood and Movement in Daily Life (MOOVD) study
to validate them [34].
Development Data Set
In short, NESDA is an ongoing multisite longitudinal cohort
study among 2981 adults (aged 18 to 65 years) at baseline,
including individuals with depressive and/or anxiety disorders
and healthy control subjects, which were recruited from the
general population. Details about the total NESDA sample are
provided elsewhere [33]. In this study, we used a subsample
from the Ecological Momentary Assessment and Actigraphy
(EMAA) substudy, which combined 14 days of ESM (5 times
a day) with continuous actigraphy [31,35]. A flowchart of the
inclusion process for this study is provided in Multimedia
Appendix 1. Individuals with a diagnosed episode of major
depressive disorder and/or dysthymia in the past month (n=43)
and individuals with no lifetime depressive or anxiety disorder
(control group, n=82) based on the Composite International
Diagnostic Interview (CIDI) [36] were included in the study.
Severity of depressive symptoms was assessed with the
self-reported Inventory of Depressive Symptomatology
(IDS-SR) [37]; the mean IDS-SR score represents moderate
depressive symptoms.
Validation Data Set
The MOOVD study is an ambulatory assessment study among
matched depressed and nondepressed individuals (n=54; aged
20 to 50 years) [34]. Depressed individuals were recruited from
3 psychiatric outpatient centers; nondepressed individuals were
recruited from the general population in the Netherlands. This
study combined 30 days of ESM (3 times a day) with continuous
actigraphy. Depressed individuals (n=27) with a major
depressive episode at the time of the interview or within two
months prior to the interview, according to the CIDI, were
included. Nondepressed individuals (n=27) were free of any
mood disorders at the moment of inclusion but were allowed
to have a history of depression (n=1, >7 years ago). Severity of
depressive symptoms was assessed with the Beck Depression
Inventory-II (BDI-II) [38]; the mean BDI-II score represents
severe depressive symptoms. Individual scores, however, range
from no/mild to severe depressive symptoms in both data sets
(IDS-SR score between 9 and 64; BDI-II score between 15 and
51).
Actigraphy Assessments
NESDA participants wore the wrist-worn GENEActiv
accelerometer (Activinsights Ltd) for 24 hours a day for 14
days. GENEActiv validity studies have demonstrated strong
correlations for criterion validity (Pearson r=0.79-0.98) [39]
and a good ability to determine sedentary behavior in adults
(aged 18 to 55 years) (Pearson r=0.81) [40]. Details of the
actigraphy measurements of the NESDA-EMAA substudy are
provided elsewhere [31]. MOOVD participants were assessed
with an Actical accelerometer (Respironics, Inc) for 24 hours
a day for 30 days. In the laboratory study, the Actical
demonstrated high reliability (intraclass correlation
coefficient=0.92) and validity (r=0.81) in adolescents [41].
More information about the actigraphy assessments of the
MOOVD study can be found elsewhere [42].
Experience Sampling Methodology (ESM)
In NESDA, participants took part in the ESM assessment for 2
weeks, during which they filled out questions on smartphones
5 times a day. The electronic diary had a fixed design with 3
hours between each beep, and the questionnaire included items
on current mood states, social interactions, daily experiences,
and behaviors [35]. Of all ESM assessments of all participants,
only 8.3% were missing and all included participants had enough
valid data points (>60 time points). In the MOOVD study,
participants completed questionnaires on an electronic diary,
the PsyMate (PsyMate BV) [43]. The electronic diary had a
fixed design with 3 beeps a day, 6 hours apart. The electronic
questionnaire contained items about mood, sleep, activities, as
well as social interactions, important events, rumination, and
self-esteem. Detailed information about the ambulatory
assessment procedure is provided elsewhere [34]. All included
participants had enough valid diary measurements (>60 time
points).
Outcome Variables
As the main outcome measure for both data sets, we used
presence or absence of a diagnosis of depression (major
depressive disorder and/or dysthymia) based on DSM-IV criteria
[44], assessed with the Composite International Diagnostic
Interview (CIDI), version 2.1. The CIDI is a fully structured
interview designed for assessing mental disorders according to
the diagnostic criteria of the Diagnostic and Statistical Manual
of Mental Disorders, fourth edition (DSM-IV) [36]. All CIDIs
were performed by well-trained research assistants, mainly
psychologists, mental health care nurses, and residents in
psychiatry. In the development data set, participants were
diagnosed with the CIDI instrument during the regular NESDA
interview wave, which was a maximum of 31 days prior to the
actigraphy and ESM assessments. In the validation data set,
participants started the actigraphy and ESM assessments
immediately following the screening CIDI.
Predictor Variables
Objectively assessed sleep, physical activity, and computed
RAR variables, as calculated from the actigraphy data, and
ESM-assessed depression-related affect and behavior were used
as predictors in our models. Preprocessing of the raw actigraphy
data was done in R using GGIR package version 1.5-18
(https://cran.r-project.org/web/packages/GGIR/) for the NESDA
data set and described elsewhere [31]. Almost all variables were
created similarly in the NESDA and the MOOVD data sets; any
exceptions are mentioned.
In the NESDA data set, physical activity was assessed as gross
motor activity per day and as minutes of moderate-to-vigorous
physical activity (MVPA) per day [45]. Objective gross motor
activity was estimated by calculating the Euclidian Norm Minus
One (ENMO) per individual per day [31]. Based on those
calculations, average estimates of gross motor activity were
estimated for each participant. To keep consistent with earlier
papers, MVPA was defined as ENMO values greater than 125
mg [31]. In the MOOVD data set, the Actical actigraphy device
did not allow the extraction of the raw actigraphy data (data in
SI units represented as acceleration in x, y, and z axes), and
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therefore the data were not processed with the GGIR package.
Instead, activity counts (AC) and activity intensity with 4
categories (sedentary, light, moderate, and vigorous) were
calculated as a measure of motor activity by an in-built
algorithm of the Actical software.
Sleep was assessed as total sleep time (TST) in hours and sleep
efficiency per night (%) [21,46]. In the NESDA data set, TST
was estimated with the GGIR package and equaled the
accumulated nocturnal sustained inactivity bouts. Sleep
efficiency was calculated as TST divided by time in bed
(estimated by the GGIR package). For the MOOVD data set,
TST was calculated as the sum of estimated sleep periods based
on the Sadeh algorithm [47]. Sleep efficiency was calculated
as a percentage of time scored as sleep during the time spent in
bed.
To characterize circadian RAR profiles, individual actigraphy
data sets were fitted to an extended cosinor model [48] using
nonlinear least-squares regression (RAR package version 1.0.0
for R). This allowed the estimation of 5 circadian curve
parameters for each participant, namely the midline estimating
statistic of rhythm (MESOR), amplitude, acrophase, α, and β,
as well as the circadian rhythmicity index (F statistic) (see
Figure 1 for more details).
To assess depression-related affect and behavior, we selected
ESM items that, in terms of content, matched DSM-V diagnostic
criteria for depression. For example, the symptom of “sad or
depressed mood” could be represented by the momentary affect
state, “I feel sad.” The following items that were present in both
data sets were included: sad or depressed mood, irritation,
appetite, energy, tiredness, loss of interest, enthusiasm, guilt,
concentration, and sleep disturbances. A complete list of
included ESM items from the NESDA and the MOOVD data
sets can be found in Multimedia Appendix 2. All items were
scored on 7-point Likert scales. The sum score of these items
calculated for each day and then averaged across 14 days
represented depression-related affect and behavior. The
person-level Cronbach α for depression-related affect and
behavior was .928 in the NESDA data set and .936 in the
MOOVD data set. Gender, age, and education level were
included in the analysis as covariates.
Figure 1. Example of rest-activity rhythm parameters derived from the extended cosinor model. The midline estimating statistic of rhythm (MESOR)
is a mean of the modeled activity curve; amplitude is the difference between the peak and trough of the fitted curve, herein estimating the range of
activity levels across the 24-hour period; acrophase is a phase marker indicating the time when the fitted curve reaches its peak (ie, time of maximal
activity levels across the 24-hour period); α is the relative width of the curve at the middle of the peak; β is an indicator of the steepness of the rise and
fall of the curve; and circadian rhythmicity index (F statistic) is an indicator of the strength of circadian rhythmicity (a goodness-of-fit measure for
which higher values indicate smaller discrepancies between actigraphy data and values predicted by the cosinor model).
Statistical Analysis
Multicollinearity for all predictor variables was checked by
calculating Spearman correlations and the variance inflation
factors (VIFs). Spearman correlations above 0.80 and VIFs
above 10 were considered to be indicative of severe collinearity
[49,50]. In this situation, 1 of the collinear variables that was
the least related to the outcome variable was removed from
further analysis. Fractional polynomials were used to check the
presence of nonlinear associations of the continuous predictors
to the outcome variable. Cubic association was found for sleep
duration (TST) and therefore was included as such in the
analysis.
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The next step was to build single-domain models for actigraphy
and ESM measurements separately. For the ESM model (1),
we included the ESM “depression-related affect and behavior”
score and covariates (age, gender, and education), as their
association to depression has been consistently shown [51,52]
and this information can be easily added to a screening tool.
The sum score was chosen instead of including the ESM items
in the analysis separately, as it was meant to mimic depressive
symptoms.
Group status = a0 + a1sum score + a2age + a3gender
+ a4education (1)
where “a” represents the regression coefficients from the model:
a1-a4 are predictor coefficients and a0 is the intercept.
To build an actigraphy model, we used a multivariate backward
stepwise logistic regression approach [53]. A baseline actigraphy
model included all actigraphy predictors (amplitude, acrophase,
α, β, F statistic, ENMO, TST, and sleep efficiency) as well as
predefined covariates (age, gender, and education). The MESOR
was found to be collinear with ENMO and the least related to
the outcome variable; therefore, it was removed from the further
analysis. Since different physical activity metrics (ENMO and
AC) were available for the development and the validation data
sets, we standardized ENMO and AC to alleviate a comparison
of the actigraphy models in two data sets. In the following steps,
we removed the least significant actigraphy variable (with the
highest P value) and compared the Akaike information criterion
(AIC) value to the AIC from the previous model. A significantly
smaller AIC indicates a better model. The procedure was
repeated until we defined the optimal combination of actigraphy
predictors based on the AIC. The regression equation for the
final actigraphy model is included below (2):
Group status = a0 + a1standardized ENMO +
a2acrophase + a3age + a4gender + a5education (2)
Building a Combined-Domains Model
A multivariable backward stepwise logistic regression model
was performed to examine what combination of predictors (ie,
actigraphy, ESM) resulted in the optimal prediction model for
distinguishing between depressed and nondepressed individuals.
Since we used a backward approach, the baseline model
included all predictors with unique information based on the
single-domain models (the actigraphy and the ESM models).
In the following models, we used a procedure where we removed
variables one by one, based on the highest P value, and checked
every time whether AIC improved until we defined the final
prediction model based on the AIC [54]. The regression equation
for the final combined-domains model is included below (3):
Group status = a0 + a1sum score + a2standardized
ENMO + a3age + a4gender + a5education (3)
Evaluation and Validation of the Single-Domain and
the Combined-Domains Prediction Models
To evaluate the performance of the combined-domains model
and the single-domain models, we utilized goodness-of-fit
indices and calibration curves and assessed the discriminative
ability of the models (the area under the receiver operating
characteristic curve [AUC]) [55]. The goodness-of-fit indices
and calibration curves evaluate how close the predicted and
observed estimates are. The AUC represents the ability of the
models to distinguish between patients with and without the
depression diagnosis and ranges from 0.5 (by chance) to 1.0
(perfect discrimination). These quality indicators of all 3 models
were compared with a basic model with only the covariates and
to each other. As suggested in the TRIPOD (Transparent
Reporting of a multivariable prediction model for Individual
Prognosis Or Diagnosis) statement [56], we performed
bootstrapping techniques for internal validation of the model
to simulate the performance of the prediction model in
comparable patient data sets.
As a next step, we performed an external validation by using
the developed single-domain and combined-domains models
from the NESDA data set to assess the predictive performance
of the models in the validation sample (ie, the MOOVD data
set), calculating the discriminative ability reflected by the AUC.
The NESDA data set was chosen to be a development data set
because it was larger than the MOOVD data set, to minimize
the possibility of overfitting while building the prediction model.
The MOOVD data set was suitable for the external validation
because inclusion criteria and measurements of depression were
similar. Again, we compared the final combined-domains
prediction model with the actigraphy and ESM models in the
MOOVD data set to check whether it still had a better fit than
the single-domain models. The results were reported according
to the TRIPOD statement [56].
Results
The characteristics of the development (NESDA) and validation
(MOOVD) data sets are given in Table 1.
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Table 1. Characteristics of development and validation data sets.
MOOVDb (n=54)NESDAa (n=125)
Control (n=27)Depressed (n=27)Control (n=82)Depressed (n=43)
Study characteristics
2012-20142014-2017Data collection period
General population, and outpatient centers for psychiatryGeneral population, primary health care, and mental health
care
Setting
Receiving a depression diagnosis 1 month before the
ESM/actigraphy assessment




Presence or absence of a depression diagnosis (MDD and/or
dysthymia) based on DSM-IV criteria
Presence or absence of a depression diagnosis (MDDd
and/or dysthymia) based on DSM-IVe criteria
Outcome
27 (50.0)43 (34.4)Prevalence of outcome,
n (%)
Sociodemographic characteristics
20 (74.1)20 (74.1)46 (56.1)29 (67.4)Female, n (%)
34.04 (8.96)34.70 (9.86)51.50 (12.70)52.14 (9.57)Age, mean (SD)




2.26 (0-10)31.33 (15-51)5.44 (0-25)34.53 (9-64)Depression severity,
mean (range)
1 (3.7)15 (55.6)4 (4.9)23 (53.5)ADh and/or BDi use, n
(%)
aNESDA: the Netherlands Study of Depression and Anxiety.
bMOOVD: Mood and Movement in Daily Life.
cESM: experience sampling method.
dMDD: major depressive disorder.
eDSM-IV: Diagnostic and Statistical Manual of Mental Disorders, fourth edition.
fIDS-SR: Inventory of Depressive Symptomatology (self-report).
gBDI-II: Beck Depression Inventory-II.
hAD: antidepressant.
iBD: benzodiazepine.
Predictors of depression in the final models were the
“depression-related affect and behavior” sum score for the ESM
model and gross motor activity (ENMO) and the time of
maximal activity levels across the 24-hour period (acrophase)
for the actigraphy model (Table 2). The combined-domains
prediction model included the “depression-related affect and
behavior” sum score and ENMO variables.
For the ESM model, the predictive capacity was 95.2%, which
is 29.6% higher than in the null (only intercept) model (65.6%).
Calibration of the ESM model was adequate with a Nagelkerke
R2 statistic of 0.904 and a Hosmer-Lemeshow goodness-of-fit
test of 0.960 (P=.998).
For the actigraphy model, the predictive capacity of the final
step of the backward selection model was 71.8% (6.2% higher
than the null model). Calibration of the actigraphy model was
adequate with a Nagelkerke R2 statistic of 0.357 and a
Hosmer-Lemeshow goodness-of-fit test of 10.678 (P=.221).
The final (combined-domains) model had the same predictive
capacity as the ESM model (95.2%). Calibration of the final
model was adequate with a Nagelkerke R2 statistic of 0.913 and
a Hosmer-Lemeshow goodness-of-fit test of 1.786 (P=.987).
In all 3 calibration plots, the slope approached the diagonal (see
Multimedia Appendix 3).
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Table 2. Predictors of depression included in the experience sampling method (ESM) prediction model, the actigraphy prediction model, and the final
combined-domains model.






















bExp(B): exponentiation of the B coefficient (odds ratio).
cSignificant P value (P<.05).
dSum score: a person-level sum score of the ESM items that represent depression-related affect and behavior.
eENMO: Euclidian Norm Minus One.
In the development data set, the discriminative ability in
predicting depression was good in the actigraphy model
(AUC=0.790) and excellent in the ESM model (AUC=0.991)
and the combined-domains model (AUC=0.993) (Table 3, Figure
2). The estimations did not meaningfully change after internal
validation. The discriminative ability of the model in the external
validation sample was reasonable in the actigraphy model
(AUC=0.648) and very good in the ESM model (AUC=0.891)
and the combined-domains model (AUC=0.892) (Multimedia
Appendix 4). Calibration of all models was adequate, with the
slope approaching the diagonal in all 3 calibration plots
(Multimedia Appendix 5). Multimedia Appendices 6 and 7
provide an overview of di erent probability thresholds and their
respective classification measures (sensitivity, specificity, and
predictive values) for all 3 models of interest in the development
and validation data sets.
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Table 3. The discriminative ability of the final combined-domains model and the basic, actigraphy, and experience sampling method (ESM) models.






aNESDA: the Netherlands Study of Depression and Anxiety.
bMOOVD: Mood and Movement in Daily Life.
cAUC: area under the receiver operating characteristic curve.
dBasic model has covariates included only (gender, age, and education).
Figure 2. The receiver operating characteristic (ROC) curves of the basic model, the experience sampling method (ESM) model, the actigraphy model,
and the combined-domains model in the development data set (the Netherlands Study of Depression and Anxiety).
Discussion
Principal Results
In this paper, we have developed 3 prediction models based on
ESM measures of depression-related affect and behaviors, on
actigraphy, and on their combination, for discriminating
currently depressed from nondepressed individuals. To our
knowledge, this is the first study that has created and compared
such models for their individual performance and for their
performance in combination, and using both internal and
external validation to test their discriminative abilities. The
ESM model had an excellent predictive potential in
discriminating depressed and nondepressed individuals in both
the development and the validation data sets. The actigraphy
model, in turn, had a reasonable predictive potential alone but
could not compete with the ESM model in predictive
performance. The combined-domains prediction model, which
included the ESM measure as well as the best combination of
actigraphy measures, was very similar to the ESM model in
performance in both the development and the validation data
sets. Hence, from the results we can conclude that the ESM and
actigraphy measures both have the potential to serve as an
additional screening tool; however, actigraphy does not have
added value when combined with ESM.
Comparison with Prior Work
The ESM sum score combined items about positive affect,
negative affect, sleep, and appetite. Measuring these
symptom-related items over a prolonged period of time resulted
in successful discrimination between depressed and
nondepressed individuals. The constructed prediction model
performed excellently, not only in the development but also in
the validation data set. In line with our findings, multiple
previous studies showed correlations between related measures,
mainly negative affect and positive affect (assessed with ESM),
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and depression [10,12,57]. Another study attempted to estimate
depressive symptoms based on the ESM items and found
significant correlations with depressive symptoms assessed with
symptom questionnaires [11]. Despite the strong correlation
between ESM-assessed depression-related affect and behavior
and depression, there have been no diagnostic prediction studies
using such ESM data. Existing literature, however, indicates
that both negative affect and positive affect play a role in
predicting relapse of depression [58,59] and future treatment
outcome [60,61]. Additionally, negative affect was found to be
predictive of depression onset in youth [62]. There are a very
limited number of prognostic studies available, focusing on
older adults [63]. Authors have identified the items “sad” and
“tired” as sensitive measures that have the potential to predict
future depression status in older adults. Although replication in
other types of samples is warranted, our results suggest that the
ESM measure has potential for screening purposes in clinical
practice.
Interestingly, self-report measures of depressive affect and
behavior largely overperformed objective measures of behavior
in distinguishing depressed from nondepressed individuals.
Researchers often make the implicit assumption that subjective
measures are inaccurate and cannot compete with objective
assessments. Self-reported affect and behavior, indeed, might
not align with actual observed affect or behavior due to a
difference between perceived and actual behavior [64].
Nevertheless, this bias in how a depressed person perceives
their own emotions and feelings might be highly useful for
predicting depression.
Although the actigraphy model showed good performance in
the development data set, its performance dropped in the
validation data set. While this discrepancy may be a signal of
worse performance in other samples, it could also partly be due
to differences in physical activity metrics in use. We found that
metrics from the GENEActiv and Actical accelerometers
(ENMO and AC, respectively) have never been directly
compared before, hence we could not apply any known formula
to transform data from one into the other. To overcome this
issue, we z-transformed ENMO and AC before the analysis to
adjust the variables to the same scale from –1 to 1. This step
improved the performance of the actigraphy model, although
it was still lower in the validation data set. Of note, it has
previously been shown that the placement of the accelerometer
device on the body influences its outcome measures in both the
level of and fluctuations in activities [65]. Wrist placement was
recommended as a basic technique to capture motor activity in
depressed patients because it records whole-body movement
and gestures [66]. In this study, the devices were worn on the
wrist, which implies that the model is only applicable to
actigraphy as measured using the wrist placement. Despite the
existing challenges and a lower predictive capacity compared
with ESM, actigraphy, being a passive data collection method,
might still be useful for screening purposes in some cases, for
example, in a situation where the use of ESM is not possible or
too bothersome for particular individuals.
In agreement with previous studies that used actigraphy data
[20-22,31,67], we have found strong associations between lower
levels of physical activity and depressive symptoms/depressive
disorders. Other RAR characteristics such as MESOR,
amplitude, α, β, and F statistic, calculated with the extended
cosinor analysis, were not sufficiently predictive when assessed
together with the overall activity level (ENMO) and therefore,
were eliminated from the model. Interestingly, the individual
associations between these parameters and depression were
significant; however, when these variables were combined, only
a few remained in the model (ENMO and acrophase). The fact
that only a few variables remained might be due to the potential
overlap of these parameters. Even though the association
between circadian rest-activity parameters and depression has
been shown previously [30,68-71], to our knowledge, there are
no studies that specifically compared the predictive ability of
various actigraphy-based parameters from different domains in
distinguishing depressed and non-depressed individuals. Hence,
future studies should further examine to what extent these
different variables are measuring partly the same concepts.
The combined-domains model had an excellent performance
that was highly similar to the performance of the ESM model.
Adding the actigraphy model component (ENMO or AC) did
not significantly improve the performance of the
combined-domains model. The explanation for this lack of
improvement might be that ESM captures part of actigraphy
variance. This overlap may be in part because both ESM and
actigraphy assess sleep; one assesses subjective sleep duration
and subjective sleep quality, while the other assesses the same
characteristics objectively. Another example of shared variance
might be that complaints like anhedonia could result in a patient
being less active and hence, the reduced physical activity may
be a result of the depressive symptoms. As in the previous
example, concentration problems could be associated with lower
sleep quality [72]. This makes questionable the hypothesis of
whether actigraphy has added value in its own right when
combined with ESM. To our knowledge, there is only 1 recent
study that attempted to predict depression by using both ESM
and actigraphy data; however, it was focused on
community-dwelling older adults, had a smaller sample size
(N=47), and had no external validation [32]. These researchers
used a wide range of various predictors based on actigraphy
and ESM in a machine learning approach to define the optimal
combination of the predictors and build a prediction model. As
in our study, these researchers developed their model on the
basis of daily mean ESM scores, and actigraphy-based daily
mean activity levels and daily sleep efficiency variables,
although the latter was removed from our prediction models.
Hence, the chosen variables showed predictive potential in
detecting depression even when different selection approaches
were applied. More details of the studies discussed in this
paragraph are provided in Multimedia Appendix 8.
Strengths and Limitations
The main strength of this study was the external validation of
the prediction models in a different and adequate data set that
prevented overstating the results [56,73]. The fact that there
were substantial differences between the 2 data sets and the
results were consistent in both data sets provides strong evidence
that the prediction models can be generalized to new patients
[73]. Finally, all constructed models include variables that are
ecologically valid and easy to measure in real life. There are
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also some limitations of the study that need to be mentioned.
First, different physical activity metrics (ENMO versus AC)
limited the ability to externally validate the actigraphy prediction
model in an optimal way. To avoid this problem in the future,
researchers should preferably use the accelerometers that allow
access to the raw data. In this case, the same output metric can
be chosen so that the algorithms for the computation will be the
same or at least comparable. Second, the development data set
had a small number of individuals in the depression groups who
reported no or mild depressive symptoms. This was most likely
due to logistic reasons typical of large cohort studies, as our
study was. Participants were diagnosed with the CIDI instrument
during the regular NESDA interview wave, which was a
maximum of 31 days prior to the actigraphy assessments,
whereas depression severity assessment with the IDS-SR
questionnaire was not necessarily done close to the actigraphy
assessment period (up to 72 days prior and two cases of 74 and
351 days after the CIDI). This situation, however, could possibly
deflate the association rather than inflate it, and the model would
have more predictive capacity in more acutely depressed
individuals. Third, the size of the validation data set was smaller
than suggested by some simulation studies, which required at
least 100 events for the validation sample. This suggestion,
however, was based on limited simulation studies and it lacks
the empirical evidence to guide research [56]. The sample size,
therefore, is often determined by the available data, as was the
case in our study [56]. Finally, both development and validation
samples were collected in the Netherlands, which limits
generalizability to countries with similar ethnicity profiles and
health care systems.
Concerning future research, the constructed ESM models
performed excellently with 14 and 30 days of continuous
measurements in the development and validation data sets,
respectively. However, if a shorter duration of ESM
measurements showed similar performance in the prediction of
depression, a shorter measurement period could potentially
reduce the burden on patients who struggle with longer ESM
regimes. Indeed, it has previously been shown that an association
between negative affect and depression can already be detected
using ESM for 6 to 7 days [60,74,75] or even 3 days [76].
Further, different accelerometer devices can differ substantially
in sampling frequency, data processing algorithms, and other
characteristics [77]. Therefore, examining various
accelerometers and possibly creating formulas for output
transformation might be valuable to facilitate the comparison
of outputs from different devices. In this study, we assessed 2
samples with currently depressed and nondepressed individuals
with moderate to severe levels of depressive symptoms.
Therefore, it remains to be seen whether the results of the
constructed models generalize to a population with more
ambiguous depressive symptoms or other psychiatric problems.
A large-scale study in the general population is needed before
recommendations can be made for the use of such prediction
models in clinical practice. If this is the case, implementation
of such a prediction tool in practice can be relatively
straightforward. First, ESM seems to be a feasible tool for
clinical practice and has the additional benefit that clients
become co-owners of the care process [78,79]. Second, the
developed algorithm for calculating “depression-related affect
and behavior” sum scores is easy to use. However, further
automation processes are needed to facilitate use of such a tool
in real-life settings, such as primary care. Finally, such studies,
including the current one, are necessary to build up empirical
evidence on mechanisms, which will be the basis for developing
medical devices in the future. Using strict regulations for such
kinds of basic research might strangle innovative studies rather
than pushing them forward.
Conclusions
To conclude, in this study we presented models to predict
depression based on ESM-assessed depression-related affect
and behavior as well as actigraphy data. The most potent
predictor was the “depression-related affect and behavior” sum
score constructed from the ESM data. The ESM model had an
excellent predictive capacity, is easy to calculate, and hence
might be feasible for future implementation in clinical practice.
The actigraphy model had reasonable performance, but there
was no added value of actigraphy in combination with ESM.
Despite the fact that the actigraphy model had a lower predictive
capacity than ESM, actigraphy could still be of value in
situations where ESM is too burdensome.
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AIC: Akaike information criterion
AUC: the area under the receiver operating characteristic curve
BDI-II: Beck Depression Inventory-II
CIDI: Composite International Diagnostic Interview
DSM: Diagnostic and Statistical Manual of Mental Disorders
ENMO: Euclidian Norm Minus One ESM: experience sampling method
IDS-SR: Inventory of Depressive Symptomatology, self-report
MESOR: midline estimating statistic of rhythm
MOOVD: Mood and Movement in Daily Life
MVPA: moderate-to-vigorous physical activity
NESDA: the Netherlands Study of Depression and Anxiety
NESDA-EMAA: Ecological Momentary Assessment and Actigraphy substudy of NESDA
RAR: rest-activity rhythm
TRIPOD: Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis
TST: total sleep time
VIF: variance inflation factor
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